PolyPeptide Group AG provided earnings guidance for the full year 2022. For the period, the company targets revenue growth of 12-14% versus 2021. The Group will continue to invest in modernizing and expanding its infrastructure with capital expenditures as % of 2022 revenue expected to be above 25%.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
31.1 CHF | +1.97% |
|
+8.74% | +77.51% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+77.51% | 1.14B | |
+56.89% | 823B | |
+39.52% | 627B | |
-6.55% | 353B | |
+15.99% | 320B | |
+7.92% | 295B | |
+13.74% | 239B | |
+13.83% | 220B | |
-0.49% | 219B | |
+7.94% | 167B |
- Stock Market
- Equities
- PPGN Stock
- News PolyPeptide Group AG
- PolyPeptide Group AG Provides Earnings Guidance for the Full Year 2022